12 Disruptive Health Tech Startups with a Global Focus on Improving Patient Care Selected to Join Plug and Play Cleveland Innovation Platform
Plug and Play Cleveland, the global innovation platform matching health tech startups and corporate partners to disrupt the healthcare system and improve patient outcomes, has announced the results of Batch 2 Selection Day. Held at both Cleveland Clinic and University Hospitals, the two-day event brought together over 300 clinical champions to hear pitches from 20 exclusive startup companies in and around the health tech field.
Cleveland Clinic's commercialization arm is eager for external innovation
ete O’Neill, executive director of Cleveland Clinic Innovations, said that partnerships with outside inventors can reduce the time and workload necessary to bring an innovation to market.
How Cleveland Clinic, UPMC and Rush executives foster a culture of innovation
Healthcare innovation, though often elusive and at times overwhelming, is what will drive hospitals and providers toward increased value and better outcomes.
It should be a steady and consistent goal to adequately fund innovations not just for the sake of patients but for physicians and other staff as well. But how do you encourage the cutting-edge within your own healthcare organization?
We interviewed three thought leaders: Cleveland Clinic Associate CIO Will Morris, MD, UPMC Chief Innovation Officer Rasu Shrestha, MD and Rush University Medical Center CIO Shafiq Rab about their foundational philosophy to innovation and the areas most ripe for disruption.
Petuum and Cleveland Clinic join forces for AI XPRIZE competition
At Petuum, we firmly believe that humans can and should collaborate with AI technology to build things that make the world better. Our mission is to industrialize AI and make the technology widely accessible and usable so that, with our intuitive machine learning building blocks, anyone can create an AI solution that addresses challenges big and small.
We are excited to announce that we are collaborating with Cleveland Clinic, a leading academic medical center, on the submission of an AI-powered diagnostic tool to the IBM Watson AI XPRIZE challenge. XPRIZE is an open challenge sponsored by IBM Watson to develop AI technology that collaborates with humans to address societal challenges. The multi-year competition closed its latest submission round on September 8 with 62 teams competing worldwide.
Cleveland Clinic, Parker Hannifin create catheter to treat brain tumors
During his two-decade career as a neurosurgeon, Dr. Michael Vogelbaum has seen little progress in the treatment ofglioblastoma, an aggressive brain cancer that is difficult to treat or cure.
Potential new class of drugs may reduce cardiovascular risk by targeting gut microbes
Developed at Cleveland Clinic, the non-antibiotic compounds, tested in animal models, prevented production of gut byproduct linked to heart attack and stroke in humans
Ohio and heartland must embrace the "innovation economy," report says
When it comes to taking advantage of the so-called "innovation-based economy," where does Ohio rank?
Plug and Play Hosts Expo Day in Cleveland
In Spring 2018, Plug and Play Cleveland Innovation Platform began its first inaugural Health & Wellness accelerator program.
Plug and Play started with about one-thousand candidates and then narrowed down that list to 50. They shared that list with the Cleveland Clinic and JumpStart and then arrived at 13 companies.
ClearFlow Announces Additional Positive US Clinical Trial Results at the 2018 NTI Critical Care Exposition
ClearFlow, Inc., a medical device company based in Anaheim, California, has announced that positive clinical trial results were presented at the National Teaching Institute (NTI) & Critical Care Exposition 2018 annual meeting on May 23rd, 2018 in Boston, MA. The findings were presented by the study principal investigator, Dr. Yvon Baribeau, of Catholic Medical Center in Manchester, New Hampshire, in a presentation titled “Active Clearance of Chest Drains Reduces Pleural Effusions and ICU Resources in patients undergoing Cardiac Surgery.”
NaviGate Cardiac Structures Inc. (“NCSI”) reports “excellent valvular function” at 1-year follow-up of first patient to receive GATE™ tricuspid valved stent via transjugular access
NaviGate Cardiac Structures Inc. (“NCSI”) announced today that the first patient to receive its replacement tricuspid valved stent via transjugular access has reached one-year post-procedure with excellent valvular function. This patient, along with 15 others treated to date under compassionate use protocols for severe tricuspid regurgitation, have received NCSI’s GATE™ tricuspid valved stent designed to lead to restored valvular function and improved quality of life.